Evaluation of Metabolic Risk Markers: Calcium/Magnesium Ratio, Lipoproteins and Insulin Resistance in Patients with Obstructive Sleep Apnea Syndrome
1Department of Clinical Biochemistry, Kayseri Training and Research Hospital, Kayseri, Turkey
2Department of Chest Diseases, Kayseri Training and Research Hospital, Kayseri, Turkey
J Clin Pract Res 2018; 40(3): 131-135 DOI: 10.5152/etd.2017.0109
Full Text PDF

Abstract

Objective[|]Obstructive sleep apnea syndrome (OSAS) is described as repetitive apnea episodes that lead to inflammation, ischemia/hypoxia, and may also have effects on mineral and metabolic markers. We aimed to examine the relationships between calcium (Ca), magnesium (Mg), the Ca/Mg ratio, insulin sensitivity–resistance markers (glucose, insulin, homeostatic model assessment indicator of insulin resistance (HOMA-IR)), cardiovascular markers (lipids, lipoproteins), and their relationships with each other, and to find out the possible influence of Ca/Mg ratio on metabolic markers in OSAS.[¤]Materials and Methods[|]Male patients’ metabolic markers and mineral levels were compared with those of control subjects.[¤]Results[|]In the OSAS group, fasting glucose and insulin levels were statistically significantly higher (p=0.004 and 0.003, respectively), and fasting glucose levels were correlated with Ca, Mg, and Ca/Mg ratios (0.012, 0.001, and 0.000, respectively). Calcium levels were correlated with HOMA-IR (p= 0.015). Severe OSAS patients had a statistically significantly higher Ca/Mg ratios (p=0.017) and HOMA-IR levels (p=0.003) than mild/moderate group, but the correlation between the Ca/Mg ratio and HOMA-IR was not statistically significant.[¤]Conclusion[|]Mg and Ca levels appear to be related to insulin resistance markers in patients. Severe OSAS patients had statistically higher Ca/Mg ratios than mild/moderate groups, so they might represent a risk group with respect to diabetes.[¤]